D.C. Mun. Regs. tit. 29, § 9106
9106.1 Medically Managed Intensive Inpatient Detoxification (MMIID), or Level IV Care, shall be a twenty-four (24) hour, medically directed evaluation and withdrawal management. Beneficiaries who are eligible for MMIID shall exhibit severe signs and symptoms of withdrawal from psychoactive substances that necessitate access to necessary primary medical and nursing care services.
9106.2 A beneficiary who is discharged from MMIID treatment shall be directly admitted into a residential substance abuse program through a “bed-to-bed” transfer unless APRA previously authorized an exception or the beneficiary refuses admission to a residential program.
9106.3 Beneficiaries discharged from MMIID who refuse admission to residential treatment programs shall become ineligible under the ASARS program for a period of six (6) consecutive months from the date of discharge from MMIID.
9106.4 A unit of MMIID service shall be one (1) day as an inpatient.
9106.5 A beneficiary who requires an MMIID stay greater than five (5) days shall obtain prior authorization. MMIID services shall not exceed ten (10) units per treatment episode.
9106.6 MMIID treatment shall be provided in free-standing, non-hospital substance abuse treatment facilities or programs that meet the standards for medical detoxification, as set forth in 29 DCMR § 2364.
9106.7 MMIID treatment shall be delivered by the following qualified practitioners:
(b) A psychologist, registered nurse, licensed independent clinical social worker, advanced practice registered nurse, licensed professional counselor, or certified addiction counselor II under the direction and supervision of a qualified physician and in accordance with applicable District of Columbia professional licensing laws.
SOURCE: Final Rulemaking published at 59 DCR 11144 (September 28, 2012).